- Home
- FRT vs PCVX Comparison
FRT vs PCVX Comparison
Compare FRT & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRT
- PCVX
- Stock Information
- Founded
- FRT 1962
- PCVX 2013
- Country
- FRT United States
- PCVX United States
- Employees
- FRT N/A
- PCVX N/A
- Industry
- FRT Real Estate Investment Trusts
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- FRT Real Estate
- PCVX Health Care
- Exchange
- FRT Nasdaq
- PCVX Nasdaq
- Market Cap
- FRT 8.1B
- PCVX 4.4B
- IPO Year
- FRT N/A
- PCVX 2020
- Fundamental
- Price
- FRT $95.80
- PCVX $33.25
- Analyst Decision
- FRT Buy
- PCVX Strong Buy
- Analyst Count
- FRT 14
- PCVX 10
- Target Price
- FRT $113.86
- PCVX $136.50
- AVG Volume (30 Days)
- FRT 699.4K
- PCVX 1.5M
- Earning Date
- FRT 08-06-2025
- PCVX 08-05-2025
- Dividend Yield
- FRT 4.59%
- PCVX N/A
- EPS Growth
- FRT 23.89
- PCVX N/A
- EPS
- FRT 3.47
- PCVX N/A
- Revenue
- FRT $1,223,588,000.00
- PCVX N/A
- Revenue This Year
- FRT $5.34
- PCVX N/A
- Revenue Next Year
- FRT $5.51
- PCVX N/A
- P/E Ratio
- FRT $27.57
- PCVX N/A
- Revenue Growth
- FRT 6.05
- PCVX N/A
- 52 Week Low
- FRT $80.65
- PCVX $27.66
- 52 Week High
- FRT $118.34
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- FRT 50.00
- PCVX 45.61
- Support Level
- FRT $93.36
- PCVX $32.00
- Resistance Level
- FRT $95.97
- PCVX $34.63
- Average True Range (ATR)
- FRT 1.54
- PCVX 1.33
- MACD
- FRT -0.09
- PCVX -0.06
- Stochastic Oscillator
- FRT 57.70
- PCVX 33.67
About FRT Federal Realty Investment Trust
Federal Realty Investment Trust is a shopping center-focused retail real estate investment trust that owns high-quality properties in eight of the largest metropolitan markets. Its portfolio includes an interest in 102 properties, which includes 26.8 million square feet of retail space and over 3,100 multifamily units. Federal's retail portfolio includes grocery-anchored centers, superregional centers, power centers, and mixed-use urban centers. Federal Realty has focused on owning assets in highly desirable areas with significant growth, and as a result, the average population density and average median household income are higher for its portfolio than for any other retail REIT.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.